.jpg)
.png)
Members in the News
Nanette K. Wenger, MD, professor of medicine in the division of cardiology at the Emory University School of Medicine, has been chosen as the recipient of the 2013 National Lipid Association (NLA) Honorary Lifetime Member Award. Emory News - June 24, 2013
By Jennifer Brown, PhD, Everyday Health Staff Writer September is cholesterol awareness month, and a good time to get your cholesterol levels checked. If your bad cholesterol, LDL, is below 100 mg/dL and your good cholesterol, HDL, is above 40 mg/dL for... more
By Jennifer J Brown, PhD, Everyday Health Staff Writer Matt Ito, PharmD, is the president of the National Lipid Association for a very good reason. He has inherited a dangerously high cholesterol condition called familial hypercholesterolemia, or FH, which affects more than 600,000... more
From Penn State News: UNIVERSITY PARK, Pa. -- Penny Kris-Etherton, distinguished professor of nutrition at Penn State, has accepted an invitation to join the Science Board of the President's Council on Fitness, Sports and Nutrition. Her three-year term on the Science Board will begin on Jan. 1,... more
Increasing obesity is one the most important healthcare problems in United States and has become a major focus of recent government initiatives to improve the health of the country. The serious effects of obesity are even greater in Indians and other South Asians especially in the case of obesity... more
By Carol Kirkpatrick, PhD, RDN, LDN, CLS, FNLA; Geeta Sikand, MA, RDN, FAND, CLS, CDE, FNLA; Ralph LaForge, MSc, CLS, FNLA In September, the National Lipid Association released its new Recommendations for Patient-Centered for Dyslipidemia Management – Part 2. These recommendations... more
By Batya Swift Yasgur, MA, LMSW In February of 2016, the National Lipid Association (NLA) released its Annual Summary of Clinical Lipidology, which is an update to Parts 1 and 2 of the NLA's “Recommendations for Patient-Centered Management of Dyslipidemia,” both published in 2015. The summary is... more
REDUCE-IT Cardiovascular Outcomes Trial Reveals Significant Reduction in Major Cardiovascular Events
Nov. 10, 2018 CHICAGO ‒ The REDUCE-IT cardiovascular outcomes trial results, announced today at the American Heart Association Scientific Sessions in Chicago, met its primary composite endpoint and revealed a reduction in major adverse cardiovascular events (MACE) of 25%. Download the... more
From University of Rochester Medica Center: University of Rochester Medical Center cardiologists are first in Upstate New York to offer a blood-cleansing therapy for people with extremely high cholesterol, including two-time heart attack survivor Bob Guesno, whose cholesterol level was nearly three... more
BY KAREN E. ASPRY AND CHARLES B. EATON The new Cholesterol Treatment Guidelines released by the American College of Cardiology and American Heart Association last November generated wide discussion. What was not debated is the high prevalence of atherosclerosis-related death and disability in... more